<
new post
StocksRunner logo
mail
search
 
menu
 
Ultragenyx Pharmaceu
$22.80
+1.29%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

RARE Stock Analysis & IQ Rating | Ultragenyx Pharmaceu

 
 

RARE

 

Ultragenyx Pharmaceu

$22.80

 
+$0.29 | +1.29%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$43.54
 
 
MKT CAP
$2.19B
 
52W Low
$18.41
 
 
VOL
$7.34K
 
P/E Ratio
N/A
 
 
AVG VOL
$2.56M
 
RSI
45.70
 
 
TREND
Downtrend
 
 
 

RARE Stock IQ

 
lock  Login to see Ultragenyx Pharmaceu (RARE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

RARE Target Price

 
 
 

Strengths

 
 

RARE Rewards

 Earnings are forecast to grow

RARE Rewards

 Trading below its fair value

RARE Rewards

 Upgraded on attractively valued

RARE Rewards

 Investors confidence is positive

 
 

RARE Price Performance

 
 

$24.62   (-7.39%)

$33.76   (-32.46%)

$30.08   (-24.20%)

$38.36   (-40.56%)

 
 
1year
6month
3month
1month

RARE Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

RARE Earnings Sentiment Above analyst estimates
RARE Earnings Sentiment Reported a weak earnings
RARE Earnings Sentiment Revenue increase YoY
RARE Earnings Sentiment Loss widens YoY
RARE Earnings Sentiment Earnings decline YoY

Rating

×

Rating

RARE Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

RARE Momentum Analysis Has been gaining momentum

Activity

×

Activity

RARE Activity Sentiment Investors confidence is positive
RARE Activity Sentiment Expands stock buyback program

Future

×

Future

RARE Future Sentiment Earnings are forecast to grow
RARE Future Sentiment Trading below its fair value
RARE Analysts Opinion

RARE Analysts opinion is negative and it remained unchanged from the past 3 months

RARE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

71%
Consensus Rating
100%
Buy
Opinion
0%
Trend
Score
100%
Potential
Score
RARE Street Sentiment

RARE Street Sentiment is bullish and have positive views on the near-term outlook

RARE Risk Level

RARE has Low risk level

RARE Risk Level
Low
LOW
HIGH

RARE Performance Sentiment

Sentiments overview associated with events and the stock performance

71%
Positive
12 out of 17
events present
29%
Negative
5 out of 17
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$19.72
Resistance Price
$27.42
Current Price Range
$22.51
$19.72
$27.42
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
6
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Dec 11, 2025

 

Reiterate

 

Buy

 

Citi

 

Nov 25, 2025

 

Reiterate

 

Overweight

 

Barclays

 

Nov 06, 2025

 

Reiterate

 

Buy

 

TD Cowen

 

Sep 30, 2025

 

Reiterate

 

Buy

 

Cantor Fitzgerald

 
 
 
Runners Also Watch
Close Price
Change
 

MREO

Mereo BioPharma Group

0.40

-1.29%

 
 
 
RARE Latest Analysis +
 
 
FAQ About RARE Stock Insights
 

What is RARE current stock price?

What are RARE stock strengths?

What is RARE Risk Level?

What is RARE market cap and volume?

What is RARE current Stock IQ?

Should I buy RARE stock right now?

Is RARE a Strong Buy right now?

What does a 'Strong Buy' rating mean for RARE?

What does a 'Strong Sell' rating mean for RARE?

What factors influence RARE's Stock IQ?

 
 
StocksRunner

Explore our RARE Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored RARE Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our RARE Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

RARE

 

Ultragenyx Pharmaceu

 
Set Alerts
 
 

Current Price

 

$22.80

 
+$0.29 | +1.29%
 
 
52W High
$43.54
 
 
MKT CAP
$2.19B
 
52W Low
$18.41
 
 
VOL
$7.34K
 
P/E Ratio
N/A
 
 
AVG VOL
$2.56M
 
RSI
45.70
 
 
TREND
Downtrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

MREO

Mereo BioPharma Group

0.40

-1.29%

 
 
 
 
 
user
 
 
 
 

RARE Price Performance

 
 

$24.62   (-7.39%)

$33.76   (-32.46%)

$30.08   (-24.20%)

$38.36   (-40.56%)

 
 
1year
6month
3month
1month
 

RARE Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

RARE Earnings Sentiment Above analyst estimates
RARE Earnings Sentiment Reported a weak earnings
RARE Earnings Sentiment Revenue increase YoY
RARE Earnings Sentiment Loss widens YoY
RARE Earnings Sentiment Earnings decline YoY

Rating

×

Rating

RARE Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

RARE Momentum Sentiment Has been gaining momentum

Activity

×

Activity

RARE Activity Sentiment Investors confidence is positive
RARE Activity Sentiment Expands stock buyback program

Future

×

Future

RARE Future Sentiment Earnings are forecast to grow
RARE Future Sentiment Trading below its fair value
RARE Analysts Opinion

RARE Analysts opinion is negative and it remained unchanged from the past 3 months

RARE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

71%
Consensus Rating
100%
Buy
Opinion
0%
Trend
Score
100%
Potential
Score
RARE Street Sentiment

RARE Street Sentiment is bullish and have positive views on the near-term outlook

RARE Risk Level

RARE has Low risk level

RARE Risk Level
Low
LOW
HIGH
RARE Performance Sentiment
Sentiments overview associated with events and the stock performance.
71%
Positive
12 out of 17
events present
29%
Negative
5 out of 17
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$19.72
Resistance Price
$27.42
Current Price Range
$22.51
$19.72
$27.42
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
6
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Dec 11, 2025
Reiterate
Buy
Citi
Nov 25, 2025
Reiterate
Overweight
Barclays
Nov 06, 2025
Reiterate
Buy
TD Cowen
Sep 30, 2025
Reiterate
Buy
Cantor Fitzgerald
 
 
 
 

RARE Stock IQ

 
 
 
lock  Login to unlock Ultragenyx Pharmaceu (RARE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

RARE Rewards

 Earnings are forecast to grow

RARE Rewards

 Trading below its fair value

RARE Rewards

 Upgraded on attractively valued

RARE Rewards

 Investors confidence is positive

 
 
 

RARE Latest Analysis

 
 
 

Ultragenyx granted FDA priority review for rare metabolic disorder gene therapy.

 

Mon Feb 23, 2026

$22.51 | -0.92%
 
Activity

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). NOVATO Calif. Feb. 20 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases today reported the grant of 22917 restricted stock units of the companys common stock to six newly hired non-executive officers of the company. The awards were approved by the compensation committee of th

 

Fri Feb 20, 2026

$22.72 | +4.08%
 
Activity

Ultragenyx Q4 Loss Wider Than Expected Revenues Increase Y/Y. RARE posts a wider-than-expected Q4 loss even as revenues jump 25% to $207 million beating estimates. It also announces a strategic restructuring plan targeting profitability in 2027.

 

Fri Feb 13, 2026

$20.52 | -12.68%
 
Activity
Earnings
Earnings

Why Is Ultragenyx Stock Sinking Friday?. ) on Thursday reported and initiated a strategic restructuring plan.“.The year ahead marks an important turning point for the company as we approach two potential product launches and a pivotal data readout that together could significantly accelerate our commercial revenue trajectory”. said “.We are implementing a strategic restructuring plan to reduce our operating expenses and ensure our resources are squarely aligned with our highest-i

 

Fri Feb 13, 2026

$20.52 | -12.68%
 
Activity
Momentum

Ultragenyx Pharma Loss Narrows. To Cut 10% Of Workforce . (RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) a biopharmaceutical company focused on ultra-rare genetic diseases on Thursday reported a fourth-quarter net loss of $129 million or $1.29 per share compared to $133 million or $1.39 per share last year.

 

Thu Feb 12, 2026

$23.50 | -1.59%
 
Activity

Ultragenyx (RARE) Reports Q4 Loss Beats Revenue Estimates. Ultragenyx (RARE) delivered earnings and revenue surprises of -7.32% and 2.01% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Thu Feb 12, 2026

$23.50 | -1.59%
 
Earnings

Ultragenyx (RARE) Reports Q4 Earnings: What Key Metrics Have to Say. Although the revenue and EPS for Ultragenyx (RARE) give a sense of how its business performed in the quarter ended December 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

 

Thu Feb 12, 2026

$23.50 | -1.59%
 
Potential
 
 
 
 
 
StocksRunner

Discover RARE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of RARE. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our RARE Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

RARE Stock trends

RARE Stock performance

RARE Stock analysis

RARE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

RARE Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing RARE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing RARE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.